Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography

被引:34
作者
Chen, CC
Wang, SS
Lu, RH
Lu, CC
Chang, FY
Lee, SD
机构
[1] Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
关键词
acute pancreatitis; cytokines; endoscopic retrograde cholangiopancreatography (ERCP);
D O I
10.1097/00006676-200305000-00011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Endoscopic retrograde cholangiopancreatography (ERCP)-induced pancreatitis provides a model to study the time course of cytokine release during the initiation phase of pancreatitis. The early changes of inflammatory cytokines after ERCP have been unclear. Aims: To evaluate the early changes in serum levels of proinflammatory and antiinflammatory cytokines after FRCP and to assess their value in the early recognition of post-ERCP pancreatitis. Methodology: Seventy-eight consecutive patients undergoing ERCP were prospectively studied. The serum concentrations of tumor necrosis factor alpha, interleukin-1beta, interleukin-6, interleukin-8, and interleukin-10 were determined immediately prior to and 1, 4, 8, and 24 hours after ERCP. Results: Seven of 78 patients (9.0%) developed post-ERCP pancreatitis. Serum levels of tumor necrosis factor alpha, interleukin-1beta, interleukin-6, interleukin-8, and interleukin-10 significantly increased at 8 and 24 hours but not at 1 and 4 hours after ERCP in patients with post-ERCP pancreatitis, in comparison with patients without pancreatitis. Using a cutoff level of 36 pg/mL for interleukin-6 at 8 hours after ERCP, we found that the sensitivity and specificity for recognition of post-ERCP pancreatitis were 100% and 87%, respectively. Serum levels of interleukin-6 and interleukin-8 modestly increased from baseline values, 1 to 24 hours after uncomplicated ERCP. Conclusion: Proinflammatory and antiinflammatory cytokines significantly increased in the early stage after ERCP-induced pancreatitis. Among the inflammatory cytokines; interleukin-6 is the most useful for recognition of post-ERCP pancreatitis.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 26 条
[1]   Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis [J].
Berney, T ;
Gasche, Y ;
Robert, J ;
Jenny, A ;
Mensi, N ;
Grau, G ;
Vermeulen, B ;
Morel, P .
PANCREAS, 1999, 18 (04) :371-377
[2]  
BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586
[3]   Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis [J].
Chen, CC ;
Wang, SS ;
Lu, RH ;
Chang, FY ;
Lee, SD .
GUT, 1999, 45 (06) :895-899
[4]  
Chen CC, 1999, AM J GASTROENTEROL, V94, P213
[5]  
CONN M, 1991, AM J GASTROENTEROL, V86, P1011
[6]   A RANDOMIZED, PROSPECTIVE-STUDY COMPARING 2 CONTRAST-MEDIA IN ERCP [J].
CUNLIFFE, WJ ;
COBDEN, I ;
LAVELLE, MI ;
LENDRUM, R ;
TAIT, NP ;
VENABLES, CW .
ENDOSCOPY, 1987, 19 (05) :201-202
[7]   Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography [J].
Devière, J ;
Le Moine, O ;
Van Laethem, JL ;
Eisendrath, P ;
Ghilain, A ;
Severs, N ;
Cohard, M .
GASTROENTEROLOGY, 2001, 120 (02) :498-505
[8]   ENDOTOXEMIA AND SERUM TUMOR-NECROSIS-FACTOR AS PROGNOSTIC MARKERS IN SEVERE ACUTE-PANCREATITIS [J].
EXLEY, AR ;
LEESE, T ;
HOLLIDAY, MP ;
SWANN, RA ;
COHEN, J .
GUT, 1992, 33 (08) :1126-1128
[9]  
FJOSNE U, 1986, ACTA MED SCAND, V219, P301
[10]   Risk factors for post-ERCP pancreatitis: a prospective, multicenter study [J].
Freeman, ML ;
DiSario, JA ;
Nelson, DB ;
Fennerty, MB ;
Lee, JG ;
Bjorkman, DJ ;
Overby, CS ;
Aas, J ;
Ryan, ME ;
Bochna, GS ;
Shaw, MJ ;
Snady, HW ;
Erickson, RV ;
Moore, JP ;
Roel, JP .
GASTROINTESTINAL ENDOSCOPY, 2001, 54 (04) :425-434